Results 81 to 90 of about 8,147 (216)

Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study

open access: yesBMC Cancer, 2019
Background To investigate the implications of prophylactic intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with D2 radical gastrectomy for locally advanced Gastric Cancer (AGC) in a randomized case control study.
Maneesh Kumarsing Beeharry   +5 more
doaj   +1 more source

Aggressive Desmoplastic Small Round Cell Tumor in an Adult: A Case Report and Literature Review

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Desmoplastic small round cell tumor (DSRCT) is a rare and highly aggressive sarcoma that predominantly affects adolescents and young adults. It is defined by a characteristic chromosomal translocation, t(11;22) (p13;q12), resulting in the EWS–WT1 fusion gene.
Seyed Amir Aledavood   +4 more
wiley   +1 more source

Umgebungsmonitoring in Operationssälen und auf Intensiv-/Pflegestationen nach HIPEC [PDF]

open access: yes, 2018
Seit die HIPEC 2013 in die deutschen Leitlinien des Kolorektalen Karzinoms als Therapieoption aufgenommen wurde, steigt die Zahl an Kliniken die HIPECs durchführen. Aufgrund der Tatsache, dass das OP- und Pflegepersonal durch die HIPEC bzw.
Schenk, Katharina-Elfrun
core  

Clinical characteristics, treatment response, and survival outcomes in melanoma patients with cavity carcinomatosis: A retrospective analysis

open access: yesInternational Journal of Cancer, Volume 158, Issue 9, Page 2418-2428, 1 May 2026.
What's new? Cavity carcinomatosis, a late manifestation of cancer, fuels tumor formation throughout a large area, most commonly the peritoneal and pleural cavities. The condition also can lead to resistance to otherwise effective treatment strategies.
Zhongqiao Lin   +6 more
wiley   +1 more source

Exploring flow rate selection in HIPEC procedures [PDF]

open access: yes, 2016
Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a main comprehensive treatment of peritoneal malignancies.
THALES PAULO BATISTA (12720853)   +2 more
core   +1 more source

Is hyperthermic intraperitoneal chemotherapy (HIPEC) safe for healthcare workers? [PDF]

open access: yes, 2017
International audienceBackgroundDuring hyperthermic intraperitoneal chemotherapy (HIPEC), caregivers are exposed by different routes to cytotoxic drugs.
Simon Rodier   +13 more
core   +1 more source

Heating technology for malignant tumors: a review

open access: yesInternational Journal of Hyperthermia, 2020
The therapeutic application of heat is very effective in cancer treatment. Both hyperthermia, i.e., heating to 39–45 °C to induce sensitization to radiotherapy and chemotherapy, and thermal ablation, where temperatures beyond 50 °C destroy tumor cells ...
H. Petra Kok   +8 more
doaj   +1 more source

The Role of Laparoscopy in Peritoneal Surface Malignancies Selected for Hyperthermic Intraperitoneal Chemotherapy (HIPEC). [PDF]

open access: yes, 2012
BACKGROUND: Cytoreductive surgery (CS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) was developed as locoregional treatment for primary or secondary peritoneal tumors. The role of laparoscopy over several stages of diagnosis and the
ROSSI, CARLO RICCARDO   +2 more
core   +1 more source

An acute cardiac complication of HIPEC [PDF]

open access: yesAsian Journal of Oncology, 2016
Recently, cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) has been described for both treatment and prevention of locoregional cancer of various origin. As this procedure involves large amount of blood and fluid loss during the CRS phase, and haemodynamic, metabolic, and coagulation changes during the HIPEC ...
openaire   +1 more source

Системное влияние цисплатина при проведении процедуры HIPEC при канцероматозе брюшины [PDF]

open access: yes, 2017
Перитонеальный канцероматоз (ПК) по различным данным, развивается в 30–40 % случаев при опухолях ЖКТ и 65–70 % – при опухолях яичников. HIPEC – это метод лечения канцероматоза брюшины и предотвращения диссеминации опухолевых клеток в брюшине, который ...
Большой, Д. В.   +2 more
core  

Home - About - Disclaimer - Privacy